The product also has the two leading moisturizers, Hyaluronic, squalane, which are now moisturized enough to make the skin moist, moist, and strong
MIDI actively advertises that they sell compounded GLP1-s, which are not recommended given all the issues with compounding
Table of Contents Understanding GLP-1 Medications and Thyroid Cancer Concerns What the Clinical Evidence Shows About GLP-1 and Thyroid Risk Thyroid Cancer Warning: Who Should Exercise Caution with GLP-1 Medications Monitoring and Safety Guidance for GLP-1 Users in the UK Discussing Thyroid Cancer Risk with Your Healthcare Provider Scientific References Frequently Asked Questions Understanding GLP-1 Medications and Thyroid Cancer Concerns Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications increasingly prescribed in the UK for type 2 diabetes management and, more recently, for weight management
PSM, propensity score matching
Hyperthyroidism, which occurs when the thyroid produces higher levels of hormones
Originally developed for type 2 diabetes, these medications have shown remarkable efficacy in not only improving blood sugar control but also addressing obesity, metabolic-associated steatotic liver disease (MASLD), chronic kidney disease (CKD), and reducing cardiovascular disease